Week Ending September 29th, 2023
Biotech: 8 Transactions (4 Follow-Ons, 2 PIPEs, and 2 RDs) totaling just under $2 Billion
Med Tech: No Current Week Transactions
2023 YTD
134 Biotech transactions totaling just under $20 Billion v. 2022: 113 Biotech transactions totaling just under $14 Billion
15 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million
Private Transactions:
Biotech: 182 Transactions / 53 European Transactions
Med Tech: 100 US Transactions / 33 European Transactions
October Major Transactions:
AbbVie acquired Mitokinin - $110M
Kyowa Kirin acquired Orchard Therapeutics - $387M; $16/Share
Eli Lilly acquired Point Biopharma - $1.4B; $12.50/Share
September Major Transactions:
Alfasigma acquired Intercept Pharmaceuticals - $794M; $19/Share
August Major Transactions:
Otsuka Pharmaceutical acquired Mindset Pharma - $59M; $0.75/Share
Harmony Biosciences acquired Zynerba Pharmaceuticals - $60M; $1.11/Share
Regeneron acquired Decibel Therapeutics - $107M; $4/Share
Comentarios